Manesh Girn
5 min
Psychedelic research has expanded rapidly, yet findings regarding the neural mechanisms of these drugs remain fragmented across independent, small-scale studies. To address this, the authors formed the BOLD Psychedelic Consortium, integrating 11 resting-state functional magnetic resonance imaging (rsfMRI) datasets from five countries. This mega-analysis included 267 participants and over 500 connectomes, covering four classic psychedelic classes: psilocybin, LSD, DMT (including ayahuasca), and mescaline. The researchers applied a uniform preprocessing pipeline and a Bayesian hierarchical modeling framework to quantify the consistency and magnitude of drug-induced changes in brain network connectivity, explicitly accounting for study- and drug-specific variability.
The study identifies a robust, cross-drug neural signature characterized by increased functional connectivity between transmodal association networks (such as the default mode and frontoparietal networks) and unimodal sensorimotor networks (visual and somatomotor). This finding suggests a flattening of the brain's intrinsic processing hierarchy under the influence of psychedelics. Additionally, the researchers observed selective increases in coupling between subcortical regions—specifically the caudate and putamen—and sensorimotor networks.
In contrast to previous reports, the Bayesian analysis revealed only weak-to-moderate and highly selective reductions in within-network functional connectivity. The authors argue that earlier claims of widespread network disintegration may have been overstated, as many within-network effects showed substantial variability and often failed to reach high-confidence levels in the Bayesian model.
By synthesizing data across multiple research groups and drugs, this study provides a foundational, reproducible map of how psychedelics alter large-scale brain organization. It resolves inconsistencies in the existing literature by applying a rigorous Bayesian framework that prioritizes effect robustness over binary statistical thresholds. These results offer a clearer neurobiological basis for understanding the acute psychedelic experience and provide a benchmark for future clinical and neuroscientific investigations into psychedelic-assisted therapies.
Psychedelic drugs are re-emerging as promising scientific and clinical tools. However, despite a rapidly expanding literature on their therapeutic value, the neural mechanisms underlying psychedelic effects remain unclear. Resting-state functional magnetic resonance imaging studies of acute psychedelic effects, conducted independently by several research groups, have so far yielded fragmented and sometimes inconsistent findings. Here, to help facilitate greater convergence, we conducted a 'mega-analysis' integrating 11 independent resting-state functional magnetic resonance imaging datasets across five psychedelic drugs (psilocybin, lysergic acid diethylamide, mescaline, N,N-dimethyltryptamine and ayahuasca) from research groups spanning three continents and five countries. By applying a uniform preprocessing pipeline and a Bayesian hierarchical modeling framework, we discovered several common features in the induced alterations to brain function across drugs and sites. Most prominently, we identified a core signature of increased functional connectivity between transmodal (default, frontoparietal and limbic) and unimodal networks (visual and somatomotor), with subnetwork specificity. Furthermore, key subcortical regions (thalamus, caudate and putamen) and the cerebellum exhibited altered coupling with sensorimotor networks. In contrast to several single-site reports, Bayesian modeling revealed weak-to-moderate and selective reductions in within-network functional connectivity, with substantial variability across drugs and networks. Together, these findings extend past work by demonstrating that psychedelics reconfigure large-scale cortical organization while selectively engaging subcortical circuitry. This study provides the most comprehensive synthesis of psychedelic brain action to date, helping resolve inconsistencies and offering a probabilistic map of how psychedelics alter large-scale brain organization. We hereby provide a cornerstone to benchmark and shepherd future psychedelic neuroimaging research.
Alex: That fits the idea of a relaxed hierarchy, with sensory input weighted more heavily and top-down expectations less so. But that's an interpretation layered on connectivity. Nothing here tests it directly, does it?
Sam: No. It's a plausible bridge to the subjective experience of altered perception, not something the imaging establishes. I'd treat the coupling pattern and the GSR robustness as the findings that carry the paper. The striatal story is a hypothesis built on top of them.
Alex: Where does the model push back? Even with a uniform pipeline, you're pooling different field strengths, repetition times, and dosing protocols.
Sam: That's the central constraint. Random effects absorb study-specific variability, but they can't retroactively fix differences in signal-to-noise across scanners. The precision of the estimates is capped by the heterogeneity of the underlying datasets. And coverage is uneven. Psilocybin and LSD have larger samples and tighter posteriors, while ayahuasca and DMT rest on smaller datasets.
Alex: So for those drugs, the estimates are closer to priors waiting for more data.
Sam: Broadly, yes. The posteriors are wider, which honestly reflects the higher uncertainty. The authors present these as probabilistic maps, not definitive laws.
Alex: Then the methodology may be the more durable contribution than any single connectivity map. The question shifts from whether an effect exists to how certain we can be about it.
Sam: That's the case for it. A framework like this can absorb future, more harmonized trials, so the estimates tighten as data accumulate. That would be a more cumulative footing than a literature of conflicting p-values.
Alex: If you want the figures and the method choices we skipped, you can generate a deep dive of this paper. The paper has the rest either way.
Sam: Thanks for listening.